Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $111.4900 (2.13%) ($105.5800 - $113.0200) on Mon. Jun. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.93% (three month average) | RSI | 59 | Latest Price | $111.4900(2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2% a day on average for past five trading days. | Weekly Trend | LGND advances 4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -2.965% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.965% (StdDev 5.93%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
5 Day Moving Average | $114.49(-2.62%) | 10 Day Moving Average | $116.51(-4.31%) | 20 Day Moving Average | $110.51(0.89%) | To recent high | -9.8% | To recent low | 75.9% | Market Cap | $1.792b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |